Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pioglitazone + Glimepiride vs Glimepiride in T2DM
NCT00770952Phase 3Completed
- Sponsor
- Takeda
- Start
- Dec 2006
- Primary completion
- Dec 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of pioglitazone in type 2 diabetes mellitus (T2DM), sponsored by Takeda. Started Dec 2006; status: completed.
02
Drugs
pioglitazone
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00770952.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00770952.